Brief: Scandinavian Chemotech Receives Positive Outcome Evaluation Of Vetiqure
Aug 10 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST :
* SCANDINAVIAN CHEMTECH RECEIVES A POSITIVE OUTCOME IN
FLORIDAWILD'S EVALUATION OF VETIQURE
* PURCHASE DECISION EXPECTED TO TAKE PLACE DURING THE FOURTH
QUARTER OF 2022
Source text for Eikon: ID:nWkr5vqsRd
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million